RxDoctor Payments Data

Konstantinos Koulogiannis, MD

Cardiovascular Disease · Morristown, NJNPI 1407042203

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 89.2% of it on its own, with 10 other manufacturers making up the rest. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$123,418in general payments, 2019–2025

Across 433 payments — averaging $285.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$110K
  • Abbott$11K
  • Medtronic$1K
  • Boston Scientific$698
  • Cardiva Medical, Inc.$80
  • Irhythm Technologies, Inc.$54
  • plus $79 from 5 others

What the payments were for

  • Consulting fees$72,44859%
  • Speaking & faculty fees$10,4138%
  • Grants$1950%
  • Travel & lodging$28,42223%
  • Food & beverage$11,94110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences274$110,134
Abbott62$11,307
Medtronic(2 entities)66$1,066
Boston Scientific21$698
Cardiva Medical, Inc.4$80
Irhythm Technologies, Inc.1$54
Pfizer1$18
Abiomed1$16
GE HealthCare1$16
AstraZeneca1$16
Amgen1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$123,418 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$56,726
Medicare patients
456
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate15$235
Atorvastatin Calcium17$222

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →